Funding for this research was provided by:
Bowel Disease Research Foundation
Received: 28 May 2020
Accepted: 6 November 2020
First Online: 20 November 2020
: KS, PJT and SOA have received honoraria from Takeda for sitting on an advisory board. PJT has received honoraria from Takeda for speaking at a symposium. Lesley Dibley: speaker’s fees from Janssen and AbbVie; consultancy fees from GL Assessments. Christine Norton: speaker’s fees from Takeda, Tillots Pharma and Ferring Pharmaceuticals. ALH has served as a consultant, advisory board member or speaker for AbbVie, atlantic, Bristol-Myers Squibb, Celltrion, Falk, Ferring, Janssen, MSD, Napp Pharmaceuticals, Pfizer, Pharmacosmos, Shire and Takeda. She also serves on the global Steering committee for Genentech.